Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Zarneni Khrani I FurazhnafiledCriticalInst Zarneni Khrani I Furazhna
Priority to BG8212987ApriorityCriticalpatent/BG49408A1/en
Publication of BG49408A1publicationCriticalpatent/BG49408A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
The premix is intended for prophylactics and therapy of colibacteriosis, eademic disease, salmonella, paratyphus and atropic rhinitis among pigs and swines, as well as of the syndrome mastitis metritis and aglaxy with mother-swines. It reduces the possility for proliferation of a significant number of bacterial infections and the creation of resistant strains of microorganisms. The medicamentose premix contains in weight%: 4,6-dimethyl-2-sulphanilamidopirymidin 0.8 - 1.2, 10% tilosine from 8.0 to 12.0 and N-2-hidroxyethyl-3-methyl-2chinoxalincarboxamid-1,4 dioxide 0.8-1.2.